- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/075 - Adénoviridae
Détention brevets de la classe C07K 14/075
Brevets de cette classe: 318
Historique des publications depuis 10 ans
12
|
9
|
22
|
31
|
23
|
23
|
32
|
33
|
39
|
10
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Regents of the University of California | 18943 |
13 |
Glaxosmithkline Biologicals S.A. | 1701 |
13 |
The Trustees of the University of Pennsylvania | 4122 |
12 |
University of Massachusetts | 2130 |
11 |
The University of North Carolina at Chapel Hill | 1928 |
11 |
The Salk Institute for Biological Studies | 436 |
9 |
Janssen Vaccines & Prevention B.V. | 337 |
6 |
Joint Stock Company "BIOCAD" | 157 |
6 |
University of Washington through its Center for Commercialization | 498 |
6 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
5 |
University of Florida Research Foundation, Inc. | 3883 |
5 |
Children's Medical Research Institute | 60 |
5 |
Institut Catala D'oncologia (ico) | 14 |
5 |
The Broad Institute, Inc. | 1584 |
4 |
Children's National Medical Center | 254 |
4 |
Fundacio Institut D'investigacio Biomedica de Bellvitge (idibell) | 66 |
4 |
GenVec, Inc. | 64 |
4 |
University of Washington | 2157 |
4 |
Angiocrine BioScience, Inc. | 39 |
4 |
Homology Medicines, Inc. | 63 |
3 |
Autres propriétaires | 184 |